MedTrace Logo

A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris

NCT03173547 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-08-10

Study results available
· View outcomes & findings →

Summary

The objective of this study is to determine and compare the safety and efficacy of topical 146-9251 cream and vehicle cream applied twice daily for 6 weeks in subjects with moderate to severe ichthyosis vulgaris (IV).

Conditions

Interventions

DRUG

146-9251 cream

146-9251 cream contains an active drug and is applied topically.

DRUG

Vehicle cream

Vehicle cream does not contain an active drug and is applied topically.

Sponsors & Collaborators

  • Crown Laboratories, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-25
Primary Completion
2019-04-30
Completion
2019-07-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03173547 on ClinicalTrials.gov